Cervical squamous cell carcinoma is one of the predominant histological subtypes of cervical cancer, with significant morbidity and mortality globally. Its management increasingly relies on the ...

Cervical squamous cell carcinoma (CESC), the most prevalent subtype of cervical cancer, remains a major global health burden driven primarily by persistent high-risk HPV infection and genetic ...

Young women with a history of cervical lesions are at 20% higher risk of developing cardiovascular disease and more likely to ...

Cervical cancer is among the more preventable cancers for people with a cervix, yet many myths and misunderstandings persist that can affect screening behaviors and hinder early detection. Clarifying ...

Cervical cancer is the fourth most common cancer for women in the world, with more than 660,000 new cases and nearly 350,000 deaths per year. Now, University of Maryland mathematicians have developed ...

Limited data are available on survival outcomes after sentinel-lymph-node biopsy alone as compared with lymphadenectomy in cervical cancer. In this multicenter, randomized, noninferiority trial, we ...

Researchers from Xinjiang Medical University used single-cell RNA sequencing to identify PI3+S100A7+ keratinocytes in early-stage HPV-positive cervical cancer. These cells interact closely with immune ...

Cadonilimab plus platinum-based chemotherapy ± bevacizumab for persistent, recurrent, or metastatic cervical cancer: Subgroup analyses of COMPASSION-16. This is an ASCO Meeting Abstract from the 2025 ...

Treatment (Tx) patterns and decision drivers in Chinese patients (pts) with locally advanced cervical cancer (LACC): Results from a national physician survey. This is an ASCO Meeting Abstract from the ...